Genopathy
Gene-Disorder Association · Article
Gene
LOC126863256
BRD4-Independent Group 4 Enhancer GRCh37_chrX:48934848-48936047
Disorder
Albinism, Oculocutaneous, Type Vii
First reported 1991
Key publication · disorder A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.Journal of medical genetics · 1991
Association Review

In brief

The association between LOC126863256 (BRD4-Independent Group 4 Enhancer GRCh37_chrX:48934848-48936047) and Albinism, Oculocutaneous, Type Vii is supported by expert-curated evidence, drawing on a single expert-curated source, which records pathogenic variants.

Sources 1
Clinical variants 1
Symptoms 14
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
LOC126863256

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Albinism, Oculocutaneous, Type Vii

The disorder

12 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

8 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
ClinVar and variant evidence

Genetic basis

1 clinical variant

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
07
Provenance

References & sources

5 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access